These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4672381)

  • 1. Synthesis of (1-(L-2-hydroxy-3-mercaptopropanoic acid))oxytocin, a highly potent analogue of oxytocin.
    Wälti M; Hope DB
    J Chem Soc Perkin 1; 1972; 15():1946-50. PubMed ID: 4672381
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis of (1-(D-2-hydroxy-3-mercaptopropanoic acid))oxytocin, a diastereoisomer of the hydroxy-isostere of oxytocin.
    Wälti M; Hope DB
    J Chem Soc Perkin 1; 1974; 2():202-5. PubMed ID: 4856211
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis of three oxytocin analogs related to (1-deaminopenicillamine)oxytocin possessing antioxytocic acitvity.
    Vavrek RJ; Ferger MF; Allen GA; Rich DH; Blomquist AT; Du Vigneaud V
    J Med Chem; 1972 Feb; 15(2):123-6. PubMed ID: 5008235
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis and some pharmacological properties of [1-(L-2-hydroxy-3-mercaptopropanoic acid), 4-threonine]oxytocin (hydroxy [4-thr]oxytocin), a peptide with strikingly high oxytocic potency and of [1-(L-2-hydroxy-3-mercaptopropanoic acid)]oxytocin (hydroxy-oxytocin).
    Manning M; Lowbridge J; Sawyer WH; Haldar J
    J Med Chem; 1976 Mar; 19(3):376-80. PubMed ID: 943546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [1-Beta-mercapto-beta,beta-pentamethylenepropionic acid]oxytocin, a potent inhibitor of oxytocin.
    Nestor JJ; Ferger MF; du Vigneaud V
    J Med Chem; 1975 Mar; 18(3):284-7. PubMed ID: 1133819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further studies of the role of the asparagine residue in oxytocin. Synthesis and biological properties of (5- , -diaminobutyric acid)oxytocin.
    Hase S; Schwartz IL; Walter R
    J Med Chem; 1972 Feb; 15(2):126-8. PubMed ID: 5008236
    [No Abstract]   [Full Text] [Related]  

  • 7. (1-beta-mercapto-beta,beta-diethylpropionic acid,4-leucine)-8-lysine-vasopressin and (1-beta-mercapto-beta,beta-diethylpropionic acid,4-leucine)oxytocin, compounds possessing antihormonal properties.
    Dyckes DF; Nestor JJ; Ferger MF; Du Vigneaud V; Chan WY
    J Med Chem; 1974 Sep; 17(9):969-72. PubMed ID: 4855467
    [No Abstract]   [Full Text] [Related]  

  • 8. (1-(1-2-Hydroxy-3-mercaptopropanoic acid))-oxytocin, a highly potent analogue of oytocin not bound by neurophysin.
    Hope DB; Wälti M
    Biochem J; 1971 Dec; 125(3):909-11. PubMed ID: 5169441
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of an amide group in place of the disulfide bridge in deamino-oxytocin.
    Hase S; Sakakibara S; Wahrenburg M; Walter R
    J Med Chem; 1972 Oct; 15(10):1017-9. PubMed ID: 4672192
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis and properties of 1-deamino-8-L-homolysine-vasopressin.
    Lindeberg G; Kyncl J; Dreyfuss P; Bodanszky M
    J Med Chem; 1972 Jun; 15(6):629-31. PubMed ID: 5030930
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis of oxytocin and related diastereomers deuterated in the half-cystine positions. Comparison of solid-phase and solution methods.
    Spatola AF; Cornelius DA; Hruby VJ; Blomquist AT
    J Org Chem; 1974 Jul; 39(15):2207-12. PubMed ID: 4859518
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis and evaluation of alpha,alpha-disubstituted-3-mercaptopropanoic acids as inhibitors for carboxypeptidase A and implications with respect to enzyme inhibitor design.
    Lee HS; Kim DH
    Bioorg Med Chem; 2003 Nov; 11(22):4685-91. PubMed ID: 14556784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (1-Beta-mercaptopropionic acid, 2-(3,5-dibromo-L-tyrosine))oxytocin, a potent inhibitor of oxytocin.
    Lundell EO; Ferger MF
    J Med Chem; 1975 Oct; 18(10):1045-7. PubMed ID: 1159688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and some pharmacological properties of (1-deamino,9-thioglycine)oxytocin.
    Jones WC; Nestor JJ; Du Vigneaud V
    J Am Chem Soc; 1973 Aug; 95(17):5677-9. PubMed ID: 4733810
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthesis of (1,6-alpha,alpha'-diaminosuberic acid)oxytocin ('dicarba-oxytocin').
    Keller O; Rudinger J
    Helv Chim Acta; 1974; 57(5):1253-9. PubMed ID: 4854571
    [No Abstract]   [Full Text] [Related]  

  • 16. Solid phase synthesis of (3,4-dileucine)-oxytocin and a study of some of its pharmacological properties.
    Wille MA; Cahn WY; Du Vigneaud V
    J Med Chem; 1972 Jan; 15(1):11-2. PubMed ID: 5061981
    [No Abstract]   [Full Text] [Related]  

  • 17. Hydroxy analogues of oxytocin and of lysine-vasopressin.
    Bisset GW; Chowdrey HS; Hope DB; Nilwises N; Wälti M
    Br J Pharmacol; 1979 Dec; 67(4):575-85. PubMed ID: 519108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The "prostaglandin step", a bottleneck in the activation of the uterus.
    Csapo AI; Csapo EE
    Life Sci; 1974 Feb; 14(4):719-24. PubMed ID: 4823627
    [No Abstract]   [Full Text] [Related]  

  • 19. (1-Beta-mercapto-beta,beta-diethylpropionic acid)-8-lysine-vasopressin, a potent inhibitor of 8-lysine-vasopressin and of oxytocin.
    Dyckes DF; Nestor JJ; Ferger MF; Du Vigneaud V
    J Med Chem; 1974 Feb; 17(2):250-2. PubMed ID: 4809260
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of the internal cross-link in oxytocin. Preparation of mercury mercaptide oxytocin derivatives.
    Sperling R; Gorecki M
    Biochemistry; 1974 May; 13(11):2347-53. PubMed ID: 4598624
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.